Efficacy of infliximab in treatment of refractory panuveitis associated with Behçet disease
Introduction. Behcet disease (BD) is a chronic multi-system disorder with manifestations in the ocular, urological, articular, and vascular systems. Tumor necrosis factor alpha is believed to play a pivotal role in BD. Therapeutic blockade of its activity by infliximab is a novel therapeutic approac...
Main Authors: | Živković Maja, Zlatanović Marko, Zlatanović Gordana, Jakšić Vesna, Hristov Aleksandra, Jovanović Svetlana |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2017-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2017/0370-81791700103Z.pdf |
Similar Items
-
The Effect of Infliximab Therapy on Maculopathy in Behcet’s Panuveitis: A Case Report
by: Ozlem G. Sahin
Published: (2011-12-01) -
Infliximab
by: İlgen Ertam Sağduyu
Published: (2022-04-01) -
Shaping the Future of Behçet’s Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies
by: Biao Li, et al.
Published: (2023-07-01) -
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
by: Abdullah Sakkat, et al.
Published: (2022-03-01) -
Infliximab in the treatment of Budd-Chiari syndrome in Behçet’s disease
by: L.B. Santos, et al.
Published: (2019-10-01)